Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Propanc Biopharma Inc (PPCB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0010 -0.0001    -9.09%
26/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,347,792
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0009 - 0.0011
Propanc Biopharma 0.0010 -0.0001 -9.09%

PPCB Recent Sentiments

 
This page contains information on users’ sentiments for the Propanc Biopharma Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Sep 26, 2022 Thalles Zandona   0.0013 Oct 21, 2022 @ 0.0010 -23.08%
Nov 11, 2021 אשס המלכים   0.0295 Nov 15, 2021 @ 0.0288 -2.37%
Feb 01, 2021 Hüseyin GÜLEL   0.5729 Feb 26, 2021 @ 0.2650 -53.74%
Oct 22, 2020 Ahmet Kon   0.0022 Nov 13, 2020 @ 0.0019 -13.64%
Jun 15, 2020 Waylon Nielson   0.0057 Jul 10, 2020 @ 0.0030 -47.37%
Apr 07, 2020 עמית עסיס   0.0250 May 01, 2020 @ 0.0135 -46.00%
Aug 07, 2019 Madis Järveots   1.4000 Aug 30, 2019 @ 1.2180 -13.00%
Jul 26, 2019 Gianfranco Messina   2.0000 Aug 16, 2019 @ 1.5000 -25.00%
Jul 01, 2019 Madis Järveots   5.4000 Jul 26, 2019 @ 2.1700 -59.81%
Jun 07, 2019 Madis Järveots   3.7500 Jun 28, 2019 @ 6.0000 +60.00%
Mar 14, 2019 Ramiro Marrero   0.0130 Apr 05, 2019 @ 0.0105 -19.23%
Jan 24, 2019 Scott Fodale   0.0154 Feb 24, 2019 @ 0.0140 -9.09%
Jan 02, 2019 Michael wiebe   0.0200 Feb 02, 2019 @ 0.0000 +100.00%
Dec 17, 2018 Andy V   0.0140 Jan 16, 2019 @ 0.0000 +100.00%
Dec 11, 2018 Tanvir Kalsi   0.0190 Jan 10, 2019 @ 0.0000 -100.00%
Dec 03, 2018 עמית עסיס   0.0250 Jan 02, 2019 @ 0.0000 -100.00%
Nov 06, 2018 Anton Naeyaert   0.0465 Dec 06, 2018 @ 0.0000 -100.00%
Oct 31, 2018 Jenna Lewandowski   0.0480 Nov 30, 2018 @ 0.0000 -100.00%
Oct 29, 2018 Keith Small   0.0620 Nov 28, 2018 @ 0.0000 +100.00%
Oct 24, 2018 Andy V   0.0682 Nov 23, 2018 @ 0.0000 +100.00%
Oct 24, 2018 Umair Ahmed   0.0685 Nov 03, 2018 @ 0.0451 -34.16%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PPCB Comments

Write your thoughts about Propanc Biopharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nov 10, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just need good news on human trials. Cancer treatment patented
Pankaj bansal
Pankaj bansal Feb 03, 2021 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its a good company with very low (535k) market cap. company has patent approved in countries like India where cancer rate is quite high. Have a look at it !
Оля Раваева
Оля Раваева Feb 03, 2021 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now its cap is 757k but one stock is 10 time cheaper. Weird. :)
Ramiro Marrero
Ramiro Marrero Mar 16, 2019 12:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When will they announce the start of phase 3 study for PRP?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email